We might have a squeeze on our hands boy and girls…
WorJackie
prije 2 mjeseca
Moderna deal
Fantastic news, and to think we were over 100$ recently without this news. Erics recent tweet actually says ...'We are proud to partner with Moderna...'
While Merck and Moderna lead the drug development, the underlying engine powering the personalized vaccine is Personalis Inc’s advanced genomic tumor-profiling technology. Moderna utilizes Personalis’s sequencing platform to analyze each patient’s unique tumor tissue and identify specific neoantigens needed to manufacture custom doses.
That technological link directly benefits Tempus AI, which previously partnered with Personalis to commercialize minimal residual disease tests and agreed to acquire Personalis for $1.5 billion last month
WorJackie
prije 2 mjeseca
Trump & Pelosi
NoRiskNoFun
prije 2 mjeseca
Tempus AI Q2 2026 earnings 📊
WorJackie
prije 4 mjeseca
Will fly one day.
Tempus AI founder and CEO Eric Lefkofsky famously stated that Tempus will have its massive "Nvidia moment" and see exponential revenue growth when reimbursement pathways open for their diagnostic algorithms. Once these AI algorithms are approved and paid for by insurers, they can rapidly scale across the company's entire hospital ecosystem
Dflinx
prije 4 mjeseca
What we thinking?
4theLongRun
prije 4 mjeseca
Finally take off from this "AI is a bubble" fear since November 2025:
MaTy5G
prije 5 mjeseci
Tempus AI - Q1 2026 results
Tempus reported a week ago and the headline numbers were solid, but the EPS miss was impossible to ignore. Revenue came in at $348.1M, up 36% YoY. EPS was -$0.71 versus an expected -$0.10 -> a massive miss that spooked a lot of people on first glance.
The EPS miss needs context though. The net loss of $125.9M includes $56.3M in stock compensation and employer payroll taxes, plus $32.3M in unrealized losses on marketable securities. Strip those out and the picture looks much less alarming. Adjusted EBITDA was -$2.8M, which is basically breakeven and a significant improvement from -$16.2M in Q1 2025.
The actual business underneath is performing well:
- Diagnostics revenue $261.1M, up 34.7% YoY, driven by oncology volume growth of 28%. MRD test volume hit ~6,500, up 500% YoY.
- Data and Applications revenue $87M, up 40.5% YoY, with the Insights segment growing 44%.
- Full year 2026 revenue guidance raised to $1.59–1.60B, with full year adjusted EBITDA expected around $65M.
The EBITDA story is important to understand here. The Q1 EBITDA loss is expected to flip to a $65M gain for the full year as high-margin data contracts shift from prepayments to quarterly revenue recognition in the back half of the year. So Q1 seasonality is a real factor, not just an excuse.
Management also flagged roughly $350M in TCV linked to 2026 revenue in their pipeline, with continued TCV growth despite significant revenue already recognized in Q1.
The cash position is fine.. $643.8M in cash and marketable securities at end of March. This isn't a company in financial trouble.
The bear case is still real though. Tempus is not profitable, stock based compensation is heavy, and the MRD volume numbers sound impressive at 500% growth but 6,500 tests is still a small absolute number. This is a company you own on faith in the long term AI in healthcare thesis, not on near term fundamentals.
If you believe the data licensing business keeps compounding and the diagnostics side scales, the setup is interesting. If you need near term profitability, this isn't your stock yet.
Jeevan12101
prije 5 mjeseci
What is driving Tempus today 😭
Been holding tempus since 70 range and I thought it was starting to look bullish whats caused it to reach 46??
NoRiskNoFun
prije 5 mjeseci
Tempus AI Q1 2026 earnings 📊
NoRiskNoFun
prije 5 mjeseci
Tempus earnings released
LazyEyeStonk
prije 6 mjeseci
The next best growth stock ?
Im in heavy on tempus, the likelyhood of the next BIG thing imo should be this one, monopoly-style stock in healthcare if it succeeds and is backed by big money. Risk is always there for these kind of projects but its the least risky risk taking leap 😆.
What other stocks do you think fall in this category ?
WorJackie
prije 6 mjeseci
Nancy & Cathie
2 fine lasses that are happy to invest in TEM.
W'or Nancy bought her portion (100k worth) and Ark continue to fill their bags. Be nice to see a turnaround, I'm sure there are a few who have suffered last couple months. A run up would be mighty fine!
ZiomalPanszczyzniany
prije 6 mjeseci
Started small position
TradingHT
prije 7 mjeseci
Tempus AI crash explained
NoRiskNoFun
prije 7 mjeseci
Tempus AI Q4 2025 earnings 📊
NoRiskNoFun
prije 7 mjeseci
Tempus earnings released.
Jeevan12101
prije 7 mjeseci
Good day oppurtunity?
Boight in mid 70s not sure if I should buy before earnings
Kirat
prije 8 mjeseci
$100+
Na ovoj se stranici možda nalazi sadržaj koji je izradila zajednica za koji platforma Trading 212 nije odgovorna. Uvijek sami provjerite sve informacije. Trading 212 pruža samo uslugu izvršenja i ne nudi investicijske savjete ili upravljanje portfeljem.
Ulaganje bez provizije za sve
Kupuj i prodaj Tempus AI Inc +1,65 $ (2,38 %) i više od 13.000 globalnih dionica i ETF-ova
Preuzmi aplikaciju
Otvori račun
Možda se primjenjuju druge naknade. Pogledaj naše uvjete i naknade.
Izgradnja bogatstva je navika. Automatiziraj je pomoću pie.
Uloži u gotove pies ili stvori vlastite odabirom među tisućama dionica i ETF-ova
Saznaj više
Saznaj više
Pogledaj video
Kupi čak i najskuplje dionice kao što su Google, Amazon i Apple
Pogledaj video
Euronext Pariz
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
Londonska burza
Euronext Lisabon
Euronext Pariz
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
Londonska burza
Euronext Lisabon
Prikaži sve instrumente trgovanja
Podrška 24/7
Prosječno vrijeme odgovora iznosi 29 sekundi
Počni graditi svoje bogatstvo sada
Pridruži se zajednici od 5 milijuna korisnika
Preuzmi aplikaciju
Otvori račun
Preuzmi mobilnu aplikaciju
Svi prikazani statistički podaci su globalni. Broj klijenata predstavlja financirane račune.
Izvrsno
Ocjena 4,6 / 5 na osnovi 105.307 recenzije/a s platforme
Trustpilot
Ocjena 4,6 / 5 na osnovi 105.307 recenzije/a s platforme
Trustpilot
Pozvan
All good
So far, I'm more than happy with Trading 212
Pozvan
daily transfer into cash Isa is great!
I like the fact that with the cash Isa
I can do a daily transfer into the account
Pozvan
Great app
Great app. ISA saving rate is really good.
Easy way to slowly build shares portfolio. Recommended highly.
Pozvan
Easy to use
Seems a good platform as I’m new to this type of savings
Pozvan
Everything is good with the app
Everything is good with the app. Very useful and easy to use.
Pozvan
Excellent investment platform
Excellent investment platform and really nice app. I’ve been using it for some time for both stocks and shares ISA and cash ISA. Second to none for range of investments in my experience.
Pozvan
I’m a new investor with Trading 212 &…
I’m a new investor with Trading 212 & I’m enjoying using the app. It takes a few days to a week or so to familiarise how to use it, but I’m enjoying each of the features & learning as I go.
Pozvan
Excellent
Excellent, easy to speak to someone, all relevant information was provided and the issue was sorted quickly and efficiently.
Pozvan
Very easy to transfer money into the…
Very easy to transfer money into the app. Clear user interface
Pozvan
Easy to use
I was told about trading 212 by a friend it’s so easy to use, deposits and withdrawals are instant it’s useful for moving money around.
Can't recommend them enough
Been using Trading 212 for a couple of years and I love it.
Use it for my cash and stocks ISA. Easy to use and transactions go through really quickly.
Can't recommend them enough.
Pozvan
Fee free and great interactive…
Fee free and great interactive experience.
A great range of investment options available.
Pozvan
Great app with awesome features!
Great app with lots of features to help learn to invest. Very professional quality and withdrawals are quick! Would recommend to anyone with any amount of investing experience.
Pozvan
Easy to use platform for UK ISA
Easy to use platform for UK ISA which I have used for 18 months to date. The interaction with other retail investors has helped grow my knowledge of investing. Charges are zero except for fx so this is a great benefit.
Pozvan
Excellent and easy to use and a good…
Excellent and easy to use and a good way for first time savers or traders
Pozvan
Very good experience
Very good experience. Very easy to use. I like the app. Transferred cash isa out for a better rate and it was really easy to do.
Would have liked to stay with Trading 212bbut don't like paying a loyalty penalty.
Pozvan
Amazing, Beginner Friendly Investment App
Very Easy UI to use compared to other similar apps, Beginner friendly and alot of accessibility.
Pozvan
Good interest rate for easy access…
Good interest rate for easy access ISA.App user friendly and provides close daily monitoring of account
Pozvan
It’s good
My experience is good and I think it’s a great way to start your investing journey.
Pozvan
I often find apps over engineered
I often find apps over engineered, big on style and lacking in substance. I find this app clear, concise and easy to use
Prikazuju se neke od pozitivnih recenzija naših klijenata
Naše nagrade
Česta pitanja
Koja je cijena dionice Tempus AI?
Trenutna cijena Tempus AI je 70,93 $.
Koji je 52-tjedni maksimum za Tempus AI?
52-tjedni maksimum za Tempus AI je 97,3 $.
Koji je 52-tjedni minimum za Tempus AI?
52-tjedni minimum za Tempus AI je 40,77 $.
Kakva je tjedna učinkovitost Tempus AI?
U proteklom tjednu cijena Tempus AI promijenila se za −7,44 %.
Kakva je mjesečna učinkovitost Tempus AI?
Tijekom proteklog mjeseca, cijena Tempus AI promijenila se za 10,33 %.
Kakva je 3-mjesečna performansa Tempus AI?
U posljednja tri mjeseca cijena Tempus AI promijenila se za 23,85 %.
Kakva je 6-mjesečna performansa Tempus AI?
U posljednjih šest mjeseci cijena Tempus AI promijenila se za 49,33 %.
Kakva je godišnja učinkovitost Tempus AI?
Tijekom protekle godine cijena Tempus AI promijenila se za −31,3 %.